Comprehensive Analysis of Clinical Trials in Prediabetes Therapies
Clinical trials in prediabetes focus on innovative treatments such as GLP-1 receptor agonists, SGLT2 inhibitors, and metformin for glucose control. Emerging therapies also include lifestyle interventions, personalized nutrition, and advanced glucose monitoring technologies to prevent progression to diabetes. These strategies aim to improve insulin sensitivity, reduce risk factors, and delay or prevent the onset of Type 2 diabetes.